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The phagocytic cells of the peripheral blood mononuclear population are a
major source of serine proteases that play essential roles in the pathophysiology
of tissue homeostasis, inflammation, and blood coagulation (1, 2) . The neutral
proteases secreted by stimulated monocytesand/or macrophages include : elastase
(3), plasminogen activators (4-7), collagenase (8, 9), as well as components of
both the coagulation (10) and complement pathways (11) . In addition to contrib-
uting to the structural reorganization of tissue, particularly at inflammatory sites,
some of these proteases also appear to be instrumental in the control of mono-
nuclear cell and tumor cell migration (12-14), as well as both the cytolytic (15)
and mitogenic activities of macrophages (16) .
The mechanism universally used to regulate the destructive effects of serine
proteases is the coordinated synthesis of specific endogenous inhibitors (1, 2,
17) . Theseserine protease inhibitors constituteafamily of closely relatedproteins
(the Serpin superfamily [18]), with the common functional feature that they trap
the protease by presenting a reactive site that provides an ideal pseudosubstrate
(17) . The target specificity of each Serpin (i.e ., Met or Val for elastase ; Leu for
chymase; Arg for thrombin) is determined by the amino acid residue located at
its reactive center . Normally this residue is the same amino acid found on the
NH2-terminal side of the peptide bond to be cleaved by the protease in the
legitimate substrate (17) . This crucial amino acid forms the basis for a Serpin
classification scheme (e.g ., Met-Serpin, Arg-Serpin etc.) (18) . The enzyme and
its inhibitor bind tenaciously to form a complex that is typically stable to boiling
in detergent (19), but is susceptible to neutrophilic cleavage with ammonium
hydroxide (20) . Failure or lack of regulation of these potent proteolytic enzymes
is known to lead to severe pathological effects (18, 21) . For example, a genetic
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or environmentally induced deficiency in the most prevalent serum Met-Serpin,
a, protease-inhibitor (API),' has been demonstrated to account for the loss of
pulmonary function associated with emphysema (22) . Conversely, an overpro-
duction of the Arg-Serpin that inhibits the action of the plasminogen activator
(PA) found in plasma, has been correlated with human thromboembolic disease
(23) .
Here we report the cDNA cloning, sequence, and chromosomal assignment of
an Arg-Serpin gene transcribed by LPS-stimulated human monocytes that is
tentatively identified as the monocyte/macrophage-derived plasminogen activa-
tor-inhibitor (PAI-2 ; nomenclature suggested by the International Committee
Thrombosis Haemostasis, Subcommittee on Fibrinolysis, June 8, 1986) activity
reported by several laboratories (5-7, 24, 25) . Our isolation of a monocyte-
derived cDNA coding for a PAI different from the endothelial cell PAI (now
designated PAI-1) clone recently reported (26-28) substantiates the previous
conclusion, based upon biochemical and immunological criteria, that these two
molecules are distinct from one another (5, 29, 30) . However, our finding that
mRNA for the monocytic PAI-2 is synthesized in substantial quantities by LPS-
stimulated endothelial cells brings into question the assumption that PAI-I
secreted by endothelial cells is the primary PAI responsible for regulation of
vascular fibrinolysis (31) . As a naturally occurring regulator of urokinase-type
plasminogen activator activity (u-PA), this monocyte-derived Arg-Serpin may
have utility both as a substitute for e-aminocaproic acid (EACA) in the therapeutic
modulation of fibrinolysis (32), as well as in the inhibition of tumor cell infiltra-
tion, metastasis, and growth (13, 14, 33) .
Materials and Methods
Molecular Cloning ofHuman Monocyte cDNA Library.
￿
The preparation of the cDNA
library from poly(A) + RNA isolated from LPS-stimulated, human peripheral blood mon-
ocytes is described in detail elsewhere (34, 35) . The clone pcD-1214 (Fig . 1) carried in
the Okayama-Berg expression vector (36) was characterized as harboring an -.,2 kb pair
(kbp) cDNA insert coding for a stimulation-specific mRNA, by virtue of its hybridization
exclusively to cDNA probes made from stimulated monocyte poly(A) + RNA (data not
shown) . This clone was used as a negative control during characterization of the cDNA
for IL-10 from this same library (34) .
DNA Sequencing and Analysis.
￿
Fragments of the pcD-1214 cDNA were subcloned into
M13 vectors in preparation for DNA sequencing by the dideoxynucleotide chain termi-
nation method (37) . Two different sequencing strategies were undertaken, both using
a-[s5S]dATP (DuPont NEN Research Products, Boston, MA) as the isotopic tracer and a
universal primer . The first approach used a 2.3-kbp Xho I fragment (Fig . 1), which was
either subcloned intact into Sal 1-digested M13mp9, or digested with a variety of
restriction endonucleases to generate convenient subfragments for both sequencing and
subcloning into appropriately digested M13mp8 or M13mp9 vectors . These subclones
were carried in the Escherichia coli hostJM 103 (38) .
The second approach used the deletion subcloning method of Dale et al . (39) . Two
M13mp9 subclones containing the entire pcD-1214 Xho I fragment cloned in opposite
' Abbreviations used in this paper:
￿
API, a,-protease inhibitor ; ATIII, antithrombin III ; EACA,
e-aminocaproic acid ; ETAF, epidermal thymocyte-activating factor; GTC, guanidinium isothiocya-
nate ; MAS, monocyte Arg-Serpin ; MDP, muramyl dipeptide ; ORF, open reading frame ; PA,
plasminogen activator ; PAI, plasminogen activator-inhibitor ; TNF, tumor necrosis factor ; t-PA,
tissue-type plasminogen activator ; TSST-1, toxic shock syndrome toxin ; u-PA, urokinase-type plas-
minogen activator .Pstl
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FIGURE l .
￿
Restriction map (not to scale) of cDNA clone pcD-1214 isolated from an LPS-
stimulated, human monocyte library constructed in the Okayama and Berg (36) expression
vector . Only sites for restriction enzymes that cleave once or twice within the cDNA insert
(solid area) are indicated. Portions of the shuttle vector derived from SV40 (shaded) are
distinguished from the pBR322 segments (line and open area) .
79
orientations were used to generate single-stranded phage DNA which was linearized by
Eco RI digestion of the template annealed to a oligonucleotide (RD22 from International
Biotechnologies Inc ., New Haven, CT) spanning the Eco RI site in the M13mp9 polylinker
region . A series of overlapping deletions on each strand of the pcD-1214 cDNA were
created precisely as described in the IBI Cyclone Manual . CompetentE . coliJM101 were
transformed with pooled samples of deleted template DNA . Clones were selected for
DNA sequencing based upon estimates of their insert size obtained by direct electropho-
resis of phage template DNA on 0.7% agarose gels . Single-stranded DNA prepared from
M13mp9 vector without an insert andM13mp9 containing an undeleted pcD-1214 Xho
I fragment served as molecular weight markers .
Nucleotide sequence obtained from the M13 subclones generated as described above
was assembled using computer programs (40) . Subsequent computer analysis of the
completed sequence was performed using a variety of software from both the University
of Wisconsin (Madison, WI) Genetics Computer Group (UWGCG) (41) and National
Biomedical Research Foundation (NBRF ; Washington, DC) packages (42, 43) .
Northern Blot Analysis . Poly(A)+ RNA isolated from guanidinium isothiocyanate
(GTC)-extracted human monocytes as described previously (34) was fractionated on 1 .5%
formaldehyde-agarose gels (44), electroblotted to Genescreen membranes (DuPont New
Research Products), and hybridized in the presence of 50% formamide/10% dextran
sulphate with a 1,256-bp Pst I-Dra I pcD-1214 fragment (Figs . 1 and 3B) according to
the protocol developed for use with Genescreen by the manufacturer. The cDNA probe
was isolated and nick-translated using established procedures . Samples (1 lag) of the
Bethesda Research Laboratories (Bethesda, MD)-Gibco Laboratories (Grand Island, NY)
RNA ladder were run in adjacent lanes on the same gel for use as molecular weight
markers . These standards were visualized after blotting by staining the Genescreen strips
with ferri-dye (45) .
Chromosomal Assignment.
￿
The gene complementary to the pcD-1214 cDNA sequence80
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was assigned to a particular human chromosome by Southern blot analysis of mouse-
human somatic cell hybrid genomicDNA as described previously (46).A panel of hybrid
cell lines was obtained, selected, and evaluated for their human chromosomal content as
published (47-49) . Human, mouse, and hybrid genomic DNAs were digested with Bgl II,
fractionated by electrophoresis in 0.7% agarose gels and blotted to Genescreen (DuPont
NEN Research Products) membranes . These blots were also probed with the internal
1,256-bp Pst I-Dra I fragment isolated from the pcD-1214 plasmid and nick translated
in the presence of a-[s2P]dCTP (DuPont NEN Research Products) to >10' cpm/,Ug by
conventional techniques . The conditions for membrane hybridization, washing, and
autoradiography were all as described previously (46) .
In Vitro Translation. The pcD-1214 cDNA insert was subcloned as a 3' truncated
(pcD-1214ADx) 1 .63-kbp Pst I-Dra I fragment (Figs . I and 3B) into the expression vector
pSP64 (Promega Biotech, Madison, WI) polylinker region in preparation for in vitro
transcription using Eco RI linearized template plasmid DNA and SP6 RNA polymerase
(Promega Biotech) as described by the manufacturer . Uncapped RNA transcripts were
translated in a rabbit reticulocyte lysate in thepresence of ["S]methionine (DuPontNEN
Research Products) and analyzed by SDS-PAGE as previously described (34) .
Results
Characterization of the Stimulation-specific ClonepcD-1214 .
￿
Restriction enzyme
analysis of pcD-1214 plasmid revealed a cDNA insert of -2 kb in length (data
not shown) . Characterization of the mRNA complementary to the pcD-1214
insert by Northern blot hybridization to monocyte poly(A)+ RNA revealed a
single species of mRNA ^-2,000 nucleotides (nt) in length, the expression of
which is clearly initiated by stimulation (either adherence or LPS) of human
monocytes (Fig . 2, lanes 1-4) . From this initial analysis, it appeared that the pcD-
1214 insert was probably a full-length copy of the template mRNA . A minor,
higher molecular size RNA (^y6 kb) that hybridizes to the pcD-1214 probe was
seen in samples containing relatively more 2-kb mRNA (e.g ., Fig. 2, lane 4) .
Since the poly(A)' RNA preparations used in this study were prepared from
GTC cell lysates, this high-molecular-weight species may represent a stable
splicing intermediate .
A preliminary survey ofpcD-1214 gene expression in IL-1-producing cells by
Northern blot analysis revealed that transcription of this gene is linked to cellular
stimulation . For example, endothelial cells from human umbilical vein synthesize
appreciableamounts ofpcD-1214mRNA only when stimulated with LPS (Fig . 2,
lanes 7and 8) . Similarly, cells of the histiocytic lymphoma cell line U937 activate
the pcD-1214 gene on exposure to toxic shock syndrome toxin (TSST-1) (50)
(Fig . 2, lane 5), whereas the keratinocyte line Colo 16 (Fig . 2, lane 6), which is a
constitutive producer of IL-1 (epidermal thymocyte-activating factor [ETAF])
(51), does not transcribe the pcD-1214 gene .
The precise kinetics of expression of the pcD-1214 gene in monocytic cells are
presently under investigation, but preliminary data from nuclear run-off exper-
iments in the monocytic leukemia line THP-1 (data not shown) indicate that, in
common with the IL-1$ gene, thepcD-1214 gene may undergo transient expres-
sion of the type found in association with many oncogenes and competence
factors (52) . This conclusion is consistent with the Northern blot data presented
in Fig. 2, which indicate that the levels of pcD-1214 mRNA in peripheral blood
monocytes 4 h after LPS stimulation (lane 4) are considerably higher than those
seen at 12 h after stimulation (lane 1) .WEBB ET AL .
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FIGURE 2 . Northern blot analysis of
expression ofpcD-1214mRNA by different
cell types in response to stimulation. All
RNA samples are poly(A)* with the excep-
tion of lanes 3and 7 . Lane 1, 100 ng 12-h
LPS-stimulated monocyte ; lane 2, 100 ng 4-
h adhered monocyte; lane 3, 10 Wg unstim-
ulated monocyte ; lane 4, 100 ng 4-h LPS-
stimulated monocyte ; lane 5, 100ng TSST-
1-stimulated U937 cell ; lane 6, 100 ng
Colo l6 keratinocyte cell ; lane 7, 10 ug un-
stimulated endothelial cell ; lane 8, 30 ng
LPS-stimulated endothelial cell . Nucleotide
lengths indicated in left margin are derived
fromRNA ladder (Bethesda Research Lab-
oratories-Gibco Laboratories) migrated in
parallel lanes of same gel .
Nucleotide Sequence ofMonocyte cDNA pcD-1214 .
￿
Dideoxynucleotide sequenc-
ing of the pcD-1214 overlapping subclones generated a complete 1,900-bp
sequencefrom both strandsof thecDNA . The nucleotide sequence of the coding
strand, together with its deduced amino acid sequence, are shown in Fig . 3A,
and a compilation of significant structural features of both amino acid and
nucleotide sequences are summarized on the restriction map shown in Fig . 3B .
Open Reading Frames .
￿
Analysis of the compiled nucleotide sequence revealed
the longest open reading frame (ORF) to be 1,248 nt commencing with the
ATG at position 73 and terminating at nucleotide 1,320 (TAA) of frame 1 as
represented in Fig . 3A.The amino acid sequence codedforby this ORF conforms
well to coding criteria such as codon utilization, amino acid constituency, and
positional base preference as determined by analysis with several different
algorithms (41, 53, 54). The initiator methionine bears a number of the features
that seem to characterize the majority of eukaryotic mRNAs sequenced thus far .
For example, it is the closest to the 5' end of the sequence, conforms perfectly
at crucial positions (capitalized below) to the Kozak consensus (ccRccATGG),
and is preceded by both in-frame (TAA at -27) and out-frame (TGA at -7)
terminators (55) .
5' and 3' Untranslated Regions.
￿
Although we have no direct evidence (e.g .,
from primer extension) to indicate that the 5' noncoding sequence represented
by the 72 by of the cDNA shown in Fig . 3A is complete, both the size of the
complementary mRNA on Northern blots (see Fig . 2) and the fact that the
cDNA sequence in pcD-1214 begins with a purine argue in favor of a full-length
clone . The 3' non-translated sequence of 580 by contains four AATAAA
(underlined in Fig . 3A) consensus polyadenylation signals (56), in addition to the
overlapping pair 17-26 by proximal to the poly(A) tail in this clone . It appears
that certain of these upstream polyadenylation signals in the pcD-1214 gene
transcripts may be used by some cells as sites for alternate processing ofmRNA .
Northern blots of THP-1 cell RNA indicate that the processed mRNA for this
gene in these monocytec-like cells is -500 nt shorter than the 2-kb species found
in monocytes and U937 cells (data not shown) . Interestingly, there is a poly(A)
addition signal located at position 1,456-1,461 in the pcD-1214 nucleotideFIGURE 3 .
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(A) Nucleotide sequence of plasmidpcD-1214 cDNA 1,900-bp insert (nucleotides
numbered above the lines). The 415-amino-acid polypeptide encoded by this sequence is
indicated by three-letter code (amino acids numbered down left margin) . Cysteine residues
are capitalized (CYS) and potential N-linked glycosylation sites are shown by an asterisk . The
solidarrowhead between Ala22 and Ser23 represents the proposed cleavage site for the signal
peptide, and the putative reactive center (P, residue) Arg33o for this Serpin is indicated with a
broad, open arrow . The 30 carboxyl amino acids (residues 347-376) that match the recently
published (30) sequence of the tryptic peptide from PAi-2 are boxed . Nucleotide sequences
of interest are highlighted as follows : 5' translational terminators, overlined ; polyadenylat
signals, underlined ; 3' AT-rich repeats, boxed.' (B) Restriction map of pcD-1214 cDNA
indicating relative positions of rare restriction enzyme sites, the ORF (s)iaded box), cysteine
residues (Q), asparagine-linked glycosylation sites (N), putative Serpin P, reactive center ( .0.),
polyadenylation signal sequences (T) and conserved 3' untranslated AT-rich sequence
(TTATTTAT) .
'These sequence data have been subm
accession number Y00630 .
tied to the EMBL/GenBank Data Librari
82WEBB ET AL.
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sequence (see Fig. 3A) that could generate a 1.5-kb mRNA similar to that seen
in THP-1 cells.
Another feature ofparticular interest within the 3'-untranslated region of this
clone (positions 1,597-1,604) is an 8-nt sequence (TTATTTAT) recently re-
ported (57) to be conserved in genes encoding inflammatory mediators, some
oncogenes, and growth factors. In fact, the degree ofhomologyto tumor necrosis
factor a (TNF-a) mRNA extends to a perfect match over a stretch of 13 nt and
there are four flanking, partial repeats (>6 nt homology) ofthe 8-mer consensus
sequence within the 3'-untranslated region ofthe pcD-1214 cDNA(Fig. 3A).The
precise significance ofthisconserved 3' sequence is not yet clear, although recent
work by Shaw and Kamen (58) suggests that it may be related to mRNA lability
and possibly provide a target for a specific RNase involved in rapid message
turnover.
Properties of the Predicted Protein.
￿
The nucleotide sequence shown in Fig. 3A
can code for a 415-amino-acid long polypeptide of 46,596 molecular weight.
This polypeptide has a hydrophobic NH2-terminus (14 of the first 20 amino
acids are nonpolar), and therefore probably represents theprecursortoasecreted
protein. A comparison of the NH2-terminal sequence of the predicted protein
with both the consensus sequences for known signal peptides (59) and a putative
signal peptidase recognition site (60), suggests that removal of the leader se-
quence would occur between the Ala22 and Ser2s residues of the pcD-1214
polypeptide (filled arrowhead in Fig. 3A). This posttranslational processing of
the precursor polypeptide would yield an extracellular protein with a molecular
weight around 43,000 containing three potential sites for N-linked glycosylation
(Asn-X-Ser/Thr, where X is not Pro [61]) and four ofthe five cysteine residues
found within the 415-amino-acid long precursor polypeptide (see Fig. 3, A and
B). The net charge ofboth the predicted precursor and mature polypeptides is
-9. Therefore, in the absence ofglycosylation, this protein would have an acidic
isoelectric point.
Homology of the Predicted Protein.
￿
A search of the NBRF protein sequence
database using the Lipman and Pearson (62) algorithm FASTP revealed that the
polypeptide encoded by the pcD-1214 clone contained substantial homology to
members of the serine protease inhibitor (Serpin) superfamily (63). The degree
of amino acid homology between the amino acid sequence predicted from the
pcD-1214 clone and the Serpins indicated by this preliminary analysis (data not
shown) was sufficiently strong (e.g., antithrombin III (ATIII), 33%; OVA 39%;
API, 31%) to suggest a tentative identification ofthe pcD-1214 polypeptide as a
monocyte-derived Serpin. A more stringent assessment of the degree of relat-
edness between this monocyte Serpin and other human protease inhibitors was
obtained by use of the NBRF program ALIGN. Fig. 4 shows the optimized
alignments ofthe carboxyl segments of three human Serpins against the mono-
cyte Serpin. Unlike FASTP, ALIGN takes into account all potential conservative
replacements in aligning sequences. Boxed regions in Fig. 4 contain structurally
similar amino acids grouped according to the classification of Toh et al. (64).
The degree ofsequencerelatedness is scored asthe numberofstandard deviation
(SD) units the alignment is displaced from an alignment of two sequences after
amino acid randomization. The align scores of 16-23 SD obtained (see table in84
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FIGURE 4 .
￿
Computer alignment of the COOH-terminal segments of selected Serpin poly-
peptides (subscript, number of aminoacids in each protein). Perfectly matched amino acids
are indicatedby a vertical line andregions of structurally similaraminoacids are boxed. The
reactive center P, residue that is crucial for substrate specificity and classifies each Serpin is
indicated by an arrow. The degree of relatedness of these Serpins is indicated by tabulation
of data (both Align Scores and percent aminoacid homology) obtained by use of the ALIGN
algorithm(see Results for explanation).
Fig. 4) in this analysis indicate that the probability that the monocyte Serpin is
not related to ATIII, API, or endothelial cell plasminogen activator-inhibitor
(PAI-1) is much less than I in 1025 (42). As indicated in Fig. 4 (open arrow), the
EAP LKLSIKIAVHKA YITIDEKGTEAAG WFLEAIPMSI---PPEVKFNKPFVFLMIE0NT
GTVLFM60VMEP 1402
Align
PAI-1
Scores (SD)
MAS ATIII
% horology
PAI-1 IAAS ATIII
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i w i i i
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FIGURE 5 .
￿
Southern blot analysis of so-
matic cell hybrids used in chromosomal
assignment of monocyte Arg-Serpin
gene . Lanes 1-5, somatic cell hybrid
DNAs ; lane 6, mouse genomic DNA;
lane 7, humangenomicDNA. Molecular
size markers (right margin) are deter-
mined from a a-Hind III digest run in
parallel on the same gel .
high degree of perfect homology around the known reactive center residues in
several of these Serpins allowed for classification of the monocyte antiprotease
as an Arg-Serpin (MAS) (18) .
Chromosomal Assignment of the Monocyte Arg-Serpin Gene.
￿
Genomic DNA ex-
tracted from a series of human-mouse somatic cell hybrids and digested with Bgl
II was analyzed by Southern blotting for the segregation of the monocyte Arg-
Serpin gene with human chromosomes . The blots were probed with the 1,256-
bp Pst I-Dra I fragment from pcD-1214 . Fig. 5 shows that this probe hybridized
strongly to 4.7- and 6.8-kbp Bgl II fragments of human DNA (lane 7) and
crosshybridized weakly to a 15-kbp mouse fragment (lane 6) . Hybrid DNAs that
contained both mouse and human sequences complementary to the Arg-Serpin
probe (Fig . 5, lanes 1-3, 5) were readily distinguishable in this analysis from
genomic DNA that contained only the mouse gene (lane 4) . Fig. 6 presents the
data obtained from Southern blot analysis of 32 independent hybrid lines with
respect to the segregation of the Arg-Serpin probe and specific human chromo-
somes. These results allowed the unambiguous assignment of the monocyte Arg-
Serpin gene to human chromosome 18, since in every instance, the presence or
absence of the human fragment pattern correlated with the retention and loss,
respectively, of this chromosome .
In Vitro Synthesis of Monocyte Arg-Serpin Polypeptide.
￿
To confirm the fidelity
of the deduced ORF postulated for the monocyte Arg-Serpin encoded within
the pcD-1214 cDNA, a subclone containing the SP6 promoter was used to
generate in vitro transcripts which were subsequently translated in reticulocyte
lysates containing [s5S]methionine . This resulted in the synthesis of a predomi-
nant, radiolabeled polypeptide with anM . of approximately 42,000 when ana-
lyzed by SDS-PAGE (Fig . 7) . The size of this protein corresponds well to that
predicted from the nucleotide sequence (46,000 mol wt) and is within the
accepted limits of variability forSDS-PAGE analysis . The minorspecies oflabeled
polypeptides with a smallerMr seen in this analysis (Fig . 7) probably represent
translation products derived from initiation at internal AUG codons with a
strong Kozak consensus sequence (-3 purine andG at +4) (55) . There are six
such positions (around residues 39, 41, 196, 327, 329, 359) within the pcD-121486
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FIGURE 6.
￿
Segregation of Arg-Serpin probe(pcD-1214) with humanchromosomesin human-
mouse cell hybrids. The pcD-1214 probe was hybridized to Southern blots containing Bg1 H-
digested DNA from the human-mouse cell hybrids listed in the Figure. (t) Indicates a
translocated piece (see translocations for details) of the chromosome is present, but not an
intact chromosome. Thetranslocations (t) were notused in calculating thepercentdiscordancy.
The Arg-Serpin segregation was determined by scoring the presence (+) or absence (-) of
human bands in the hybrids on theblots. Thedata are compiled from 32 somaticcell hybrids
between 13 unrelated human, and 4 mouse cell lines. The hybrids were characterized by
chromosome analysis, mapped enzyme markers, and partly by mapped DNA probes. Concor-
dant hybrids either retained or lost the Arg-Serpin gene, together with a specific human
chromosome. Discordant hybrids either retained the gene, but not a specific chromosome, or
the reverse. Percent discordancy indicates the degree of discordant segregation for a marker
anda chromosome. A 0% discordancy is the basisforchromosome assignment.
transcripts. Internal initiation of this type has been described elsewhere for
eukaryotic translation systems (65, 66).
Discussion
Nucleotide sequencing of thestimulation-specific clone pcD-1214 isolated from
an LPS-stimulated, human monocyte cDNA library (34, 35) revealed an ORF
ATR-13
OLA-38SAGA
OU A-58SA04
MM-13
+ + + + + + + + + - + - + + + + + + + + - - - t
- -+----++----++--+------
+ - - + - + - - - - - + - - + - - + + - - + - -
+ + + + - + + + - - + + + - + t + + + + + + + t
- - - + - + - - + - + - + - + + + - - - + - - +
5/X
X/15
ICL-15 - -------+---+----+--++--
JSR-2 - - - + + - - + - - - - - + + - - - - - - - - +
.SR-14 - - + + + + + - - - - - + + - _ - + - - + + - +
NSL-1B + - - + + + - + + t + - + - + + + + + - + + - - 17/9
RE11-7 + + + + + + + + + - + + + + + + - + + + + + + +
REII-8O - - - - + - - - + - - - - - + - - + - _ + + + +
RE11-10 + +++++++++++++++++++,++-+
REl1-11 - - - _ + - - + - - - + + + _ - + - - - + + + +
REX-118SlgB + - - + - - - - - - + - - - + + - - + - - - - -
REX-118Sfi + --+------+---+---+---t t 2Z/X
SIR-8 + + + + + + - + + + + + + + + + + + + - - + + +
SIR-11 - ------+-----+-------+++
TSL-1 + - - + + - - - - + + + - + + - + + + - + + - -
TSL-2 + - + t - + + - - - + - + - _ - - t + - + + - +
VTL_ - - + - - - + + + - + + - - - + - + - + + + + -
11TL-9 - - - - - - - - - - - - - + - + - + - - + + + -
YR-17 - - - - - + - + - - + + - + + - - + - - + + - -
IIIL-2 - -------+---+--+-+---+-+
l1IL-5 + --_+---+-+------++--+-+
IIIL-6 - - + - + + + + + - + + - - + - - + - + + + - +
111L-8X + - - + + + - + + - + + + - + - - + + + + + - +
IIIL-BY + --+--+++-++--++++++++++
IIIL-13 + - - + - + - - - - - - - + - - - + + - - + + -
IlIL-14 - - - + - - - + + - + - - - + + - + - - - - _ +in
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monocyte Arg-Serpin clone confirm transcriptional activity of this gene in these
cells (Fig . 2, lane 5) . Definitive confirmation that our monocyte cDNA clone
pcD-1214 codes for PAI-2 will awaitfunctional assays of therecombinantprotein
(e.g ., PA substrate binding assay by SDS-PAGE analysis of substrate-inhibitor
complex ; kinetic analysis of PA substrate inhibition) . However, a brief report
appeared recently (67) on the isolation of PAI-2 clones from a human placental
cDNA library. This placental cDNA also codes for a 415-amino-acid Arg-Serpin
and publication of the complete sequence will allow its identity to our pcD-1214
clone to be verified .
Several studies (5-7) have identified stimulated monocytes/macrophages as a
major source ofu-PA . Urokinase is synthesized as a prepropolypeptide (68), but
is secreted as a single-chain, zymogenic prourokinase (69) . Proteolysis yields a
two-chain, active u-PA, the NH2-terminal portion of which binds to specific
monocyte-membrane receptors, while the catalytic COOH-terminal domain pro-
trudes from the cell surface to facilitate localized proteolysis (70) . The control
of tissue proteolysis brought about by monocyte secretion of u-PA appears to be
regulated by a corresponding monocyte-derived PAI (PAI-2) that has most
recently been characterized as having a pI around 5, and an Mr on SDS-PAGE
of 47,000 (30) . Human monocytes/macrophages secrete their specific PAI-2
after stimulation with either LPS (7), PMA (5), or muramyl dipeptide (MDP)
(71) .
The primary role of PA is to mediate the conversion of the plasma zymogen
plasminogen to produce plasmin, an endopeptidase that degrades fibrin (69) .
Endotoxin-stimulated macrophages area source of plasmin and have been shown
to hydrolyze fibrin (6), probably more effectively by the action of prourokinase
rather than mature u-PA (72) . However, the tissue-type plasminogen activator
(t-PA) and its corresponding fast-acting inhibitor produced predominantly by
endothelial cells (PAI-1) have traditionally been considered to be the primary
molecules in the homeostatic control of the fibrinolytic system (32, 73) . In
addition to its potential role in fibrinolytis, u-PA activity has been specifically
implicated in the destruction of connective tissue that is a prerequisite to both
normal macrophage interstitial migration (74), as well as the analogous process
involved in tumor metastasis (13, 14) and stroma production (33) .
The assignment of the monocyte Arg-Serpin gene to human chromosome 18
provides a useful marker on a relatively poorly mapped chromosome in the
genomeand establishesa firm genetic basis for the study of inherited deficiencies
in this gene that might be manifested clinically as various fibrinolytic, thrombo-
lytic, inflammatory, and even metastatic conditions (75) resulting from unre-
stricted release of plasmin by PA . Recently the PAI-1 gene was reported to be
located on human chromosome 7 (28) . The other Serpins mapped to-date
include : ATIII to the long arm ofchromosome 1 (lg23-q25) (76, 77), API and
al-antichymotrypsin to the long arm of chromosome 14 (14g31-q32) (78, 79),
and the recently recognized antiprotease thyroxine-binding globulin, on the long
arm of the X-chromosome (80) . The u-PA gene has been localized to 10g24-
qter (81), whereas the t-PA gene is on chromosome 8p12 (81, 82).
Perhaps the most striking observation from the present study is the demon-
stration that the monocytic Arg-Serpin gene appears to be very active in endo-thelial cells after stimulation with LPS (Fig. 2, lanes 7 and 8) . This is in contrast
to the PAI-1 which has been found to be synthesized constitutively by these cells
(26, 29, 83, 84). The possibility that PAI-1 and PAI-2 are both synthesized by
endothelial cells may warrant a reassessment of the relative importance of PAI-
1 and PAI-2 in endothelial cell control of fibrinolysis and localized vasculitis
associated with tumor cell penetration . In some respects PAI-2 could be consid-
ered a physiologically more viable candidate for modulation of intravascular PA
activity than PAI-1 . For example, PAI-1 is secreted by endothelial cells as a
latent inhibitor that can only be activated in vitro by treatment with SDS (85)
and presumably also requires some cofactor in vivo to achieve full biological
activity . The extent to which PAI-2 gene expression is under similar mechanisms
of control in both monocytic and endothelial cells is now a major focus of our
attention .
Summary
An LPS-stimulated, human monocyte cDNA library was screened for stimu-
lation-specific clones . One clone (pcD-1214) contained a 1 .9-kb pair insert that
hybridized to a 2,000-nucleotide mRNA expressed by peripheral blood mono-
cytes, the histiocytic lymphoma cell line U937, and umbilical cord endothelial
cells. The 415-amino-acid precursor polypeptide predicted from the cDNA
(46,596 molecular weight) has a putative 22-residue signal peptide and ^-35%
homology with members of the serine protease inhibitor (Serpin) superfamily .
On the basis ofamino acid homology and alignment ofCOOH-terminal residues
within the Serpin-reactive center, the clone pcD-1214 was identified as coding
for an Arg-Serpin . Southern blot analysis of human-mouse somatic cell hybrid
DNA locates the Arg-Serpin gene on human chromosome 18 . A perfect match
between amino acid residues 347-376 in this Arg-Serpin and the published
sequence of a 30-residue, tryptic peptide from the COOH-terminus ofa mono-
cyte plasminogen activator-inhibitor (PAI-2), strongly suggests that the Arg-
Serpin encoded by pcD-1214 is PAI-2 .
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Note added in proof . After the submission of this article for publication, the complete
nucleotide sequence ofhuman placental PAI-2cDNA was reported (86) . The near-perfect
homology between these two sequences confirms the conclusion that our clone pcD-1214
codes for human PAI-2 . Apart from an additional 17 nucleotides in the 5' untranslated
region of the monocyte sequence reported here, the two nucleotide sequences differ at
only 8 positions out of 1,900 . Four of these differences are located within the coding
region, although only three result in alterations of the deduced amino acid sequence .
These differences are as follows : residue 120, placenta Asp(GAT), monocyte Asn(AAT) ;
residue 393, placenta Pro(CCG), monocyte Pro(CCT) ; residue 404, placenta Lys(AAG),
monocyte Asn(AAC) ; residue 413, placenta Cys(TGC), monocyte Ser(TCC) .
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